Shanghai, China, February 04, 2024 – MicroPort EverPace's latest generation Columbus™ 3D EP Navigation System (Columbus™) has recently received CE MDR approval.
The 3D EP Navigation System represents a groundbreaking advancement in tachyarrhythmia treatment. This system merges hardware circuits, software systems, and core algorithms, resulting in a lengthy R&D cycle and high technical barriers. To fulfill clinical needs for high precision, stability, and reliability, the system places high expectations on its components and overall structure.
The latest generation Columbus™ System includes two models. The EPE-SYS-2A, building upon its predecessor, adds an electrical positioning module and offers a new software interface more closely aligned with clinical needs. The Model EPE-SYS-1A features a completely new system architecture. It boasts enhanced signal processing capabilities, more electrode positioning and signal channels. Additionally, it integrates a direct catheter interface, electromagnetic positioning, ECG signal acquisition, and other modules, meeting higher precision clinical needs and providing more valuable information for clinical applications.
To date, the Columbus™ system has successfully completed over 50,000 tachyarrhythmia treatments. In the future, MicroPort EverPace will remain committed to providing more high-quality and innovative products to the global market, ensuring comprehensive electrophysiology treatment and diagnostic solution for patients worldwide.
About MicroPort EverPace
Founded in 2010, MicroPort EverPace (Shanghai MicroPort EP MedTech Co., Ltd; SSE: 688351), an associated company of MicroPort® (MicroPort Scientific Corporation; HKEX: 00853), is a global medical devices company focusing on the development, manufacturing, and commercializing minimally invasive medical devices for the treatment of cardiac arrhythmia. It has developed a family of advanced cardiac ablation catheters, diagnostic catheters, and 3D navigation systems. These solutions are used by hundreds of physicians at over 900 hospitals over more than 30 countries. MicroPort EverPace strives to provide integrated therapeutic solutions to apply precise navigation on interventional procedures, dedicated to providing high quality therapeutic solutions to patients and physicians across the globe.
More information is available at www.everpace.com/en